US regulator, Amgen reach deal to unblock biopharma acquisition

by

The US Federal Trade Commission (FTC) announced an agreement on Friday allowing American drug manufacturer Amgen to proceed with its $28 billion takeover of Horizon Therapeutics.

Leave A Comment

Your email address will not be published. Required fields are marked *